FILIP: Fat Intake, Inflammation and LIPids
FILIP
1 other identifier
interventional
25
1 country
1
Brief Summary
Low-grade inflammation is involved in the pathogenesis of type 2 diabetes and cardiovascular disease. Increasing evidence suggests that dietary intake may be involved in the inflammatory process. How nutritional composition of the diet affects the inflammatory response is however not well understood. The aim of this project is to study if intake of three different fat sources induce different effects on inflammation markers, blood lipids, blood glucose and the microbiota.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
April 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2025
CompletedFebruary 4, 2026
April 1, 2025
8 months
October 10, 2024
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Total cholesterol
Baseline and 1 week
hs-CRP
High sensitivity C-reactive Protein
Baseline and 1 week
Secondary Outcomes (4)
Inflammation markers
Baseline and 1 week
Blood lipid propfile
Baseline and 1 week
Glucose
Continuous during 1 week
Microbiota
Baseline and 1 week
Study Arms (6)
Sequence 1: Rapeseed oil, butter, coconut oil
EXPERIMENTALDiets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Sequence 2: Rapeseed oil, coconut oil, butter
EXPERIMENTALDiets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Sequence 3: Butter, coconut oil , rapeseed oil
EXPERIMENTALDiets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Sequence 4: Butter, rapeseed oil, coconut oil
EXPERIMENTALDiets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Sequence 5: Coconut oil, rapeseed oil, butter
EXPERIMENTALDiets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Sequence 6: Coconut oil, butter, rapeseed oil
EXPERIMENTALDiets rich in rapeseed oil, butter or coconut oil given in blinded, preprepared meals
Interventions
During 1 week, 46 % of total energy intake will come from rapeseed oil, using pre-prepared and blinded meals.
During 1 week, 46 % of total energy intake will come from butter, using pre-prepared and blinded meals.
During 1 week, 46 % of total energy intake will come from coconut oil, using pre-prepared and blinded meals.
Eligibility Criteria
You may qualify if:
- Age 18-60
- Willing to eat the study diet
You may not qualify if:
- malabsorption-related condition
- contraindications to consume a high fat diet
- intolerance to any foods used in the study (e.g. cow's milk, egg, gluten)
- established cardiovascular disease, diabetes or cancer
- current use of medication known to affect lipid metabolism (e.g. statins) or inflammation (e.g. NSAID, glucocorticoids).
- hemoglobin \<100 g/L
- ongoing pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Göteborg Universitylead
- Chalmers University of Technologycollaborator
Study Sites (1)
University of Gothenburg
Gothenburg, 40530, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Meals identical in apperance and taste will be prepared, and blinded.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2024
First Posted
October 15, 2024
Study Start
April 8, 2025
Primary Completion
December 17, 2025
Study Completion
December 17, 2025
Last Updated
February 4, 2026
Record last verified: 2025-04